bf/NASDAQ:RGNX_icon.jpeg

COM:REGENXBIO

REGENXBIO

  • Stock

USD

Last Close

9.18

22/11 21:00

Market Cap

529.01M

Beta: -

Volume Today

684.38K

Avg: -

  • name

    REGENXBIO Inc.
  • homepage url

    www.regenxbio.com
  • country

    USUnited States
  • employee count

    344
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    90.24M

Description

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene ...Show More

peer of

competitor of